RESEARCH ARTICLES
Volume 9 |Issue 3| May-June 2021                                 First published: 30 June 2021
Glycosylation pattern in the glycoproteins of the Makona variant of Ebola virus
Mahale Kiran1*, Patole Milind1 and Walhe Rajan2*
1National Centre for Cell Science, SP Pune University Campus, Pune 411007, India.
2Department of Microbiology, MES Abasaheb Garware College, Pune 411004, India.
*Correspondence: kkmahale@gmail.com, rawalhe@rediffmail.com
Abstract
Keywords:Ebola Virus, Makona, Vaccine, N-glycosylation, O-glycosylation
Editor: Dr.Arvind Chavhan
Cite this article as:
Mahale Kiran, Patole Milind and Walhe Rajan. Glycosylation pattern in the glycoproteins of the Makona variant of Ebola virus, Int. Res. Journal of Science & Engineering, 2021, Volume 9(3): 71-76.
References
1. Martinez O, Ndungo E, Tantral L, Miller EM, Leung LW, Chandran K, Basler CF. A Mutation in the Ebola Virus Envelope Glycoprotein Restricts Viral Entry in a Host Species- and Cell-Type-Specific Manner. Journal of Virology. 2013; 87 (6) :3324 –3334.
2. Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, Kawaoka Y, et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Archives of virology. 2010; 155 (12): 2083-2103.
3. Mahale KN, Patole MS. The crux and crust of ebolavirus: analysis of genome sequences and glycoprotein gene. Biochemical and biophysical research communications. 2015; 463 (4): 756-761.
4. Kuhn JH, Andersen KG, Baize S, Bào Y, Bavari S, et al. Nomenclature-and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses. 2014; 6 (11): 4760-4799.
5. Ito H, Watanabe S, Takada A, Kawaoka Y. Ebola Virus Glycoprotein: Proteolytic Processing, Acylation, Cell Tropism, and Detection of Neutralizing Antibodies. Journal of Virology. 2019; 75 (3): 1576–1580.
6. Sanchez A, Kiley MP, Holloway BP, Auperin DD. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus research. 1993; 29 (3): 215-240.
7. Manicassamy B, Rong L. Expression of Ebolavirus glycoprotein on the target cells enhances viral entry. Virology Journal. 2009; 6 (75):1-15.
8. Lin G, Simmons G, Po¨hlmann S, Baribaud F, Ni H, Leslie G, Haggarty BS, Bates P, Weissman D, Hoxie JA, Doms RW. Differential N-Linked Glycosylation of Human Immunodeficiency Virus and Ebola Virus Envelope Glycoproteins Modulates Interactions with DC-SIGN and DC-SIGNR. Journal of Virology. 2003;77 (2): 1337–1346.
9. Cook JD, Lee JE. The secret life of viral entry glycoproteins: moonlighting in immune evasion. PLoS pathogens. 2013; 9 (5): e1003258.
10. Bagdonaite L, Wandall HH. Global aspects of viral glycosylation. Glycobiology. 2018;28 (7): 443–467.
11. Watanabe Y. Bowden TA, Wilson IA, Crispina M. Exploitation of glycosylation in enveloped virus pathobiology. BBA - General Subjects. 2019; 1863: 1480–1497.
12. Volchkov VE, Feldmann H, Volchkova VA, Klenk HD. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proceedings of the National Academy of Sciences. 1998; 95 (10): 5762-5767.
13. Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochimica et Biophysica Acta (BBA)-General Subjects. 1999; 1473 (1): 4-8.
14. Krieg J, Hartmann S, Vicentini A, Gläsner W, Hess D, Hofsteenge J. Recognition signal for C-mannosylation of Trp-7 in RNase 2 consists of sequence Trp-xx-Trp. Molecular biology of the cell. 1998; 9 (2): 301-309.
15. Vigerust D, Shepherd VL. Virus glycosylation: role in virulence and immune interactions. Trends in Microbiology. 2019; 15 (5): 211-218.
16. Iraqi M, Edri A, Greenshpan Y, Kundu K, Bolel P. et al. N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion. Frontiers in cellular and infection Microbiology. 2020; 10 (48): 1-11.